{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T04:29:49Z","timestamp":1787632189609,"version":"build-2736575974"},"reference-count":20,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T00:00:00Z","timestamp":1523923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Endocrinology"],"published-print":{"date-parts":[[2018,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>It is necessary to stimulate serum thyroid-stimulating hormone (TSH) levels either endogenously by thyroid hormone withdrawal (THW) or exogenously by administration of recombinant human TSH (rhTSH) for radioactive iodine (RAI) therapy. Thyrotropin alfa (Thyrogen) has many advantages over THW. Radiation dose to laboratory staff while drawing blood for tests on the day 5 is one of the disadvantages of preferring Thyrogen. Our aim was to compare day 3 and day 5 blood test results after Thyrogen injections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and method:<\/jats:title>\n                    <jats:p>In our study, Thyrogen was preferred in 32 differentiated thyroid cancer patients with a mean age of 50.5 \u00b1 12.3 years. Thyrogen was injected on day 1 and day 2 intramuscularly in all patients before I-131 was given on day 3. A total of 22 patients received 5 mCi RAI for ablation control scintigraphy and 10 patients received 100\u2013250 mCi RAI for ablation or therapy (high-dose group). Blood tests were performed on day 3 and day 5 after Thyrogen injections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Mean TSH level was 98.1 mg\/dl for day 3 and 29.5 mg\/dl for day 5. In the diagnostic group, thyroglobulin (Tg) and anti-Tg levels were nearly the same on day 3 and day 5. In the therapy group, day 5 Tg levels were higher than day 3.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>After Thyrogen injection of two consecutive days, blood sampling might be enough on day 3. Day 5 blood sampling may not be necessary routinely for radiation protection of laboratory staff. For the diagnostic group, if Tg and anti-Tg is normal then 5 mCi imaging may not be necessary.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/2042018818770108","type":"journal-article","created":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T06:41:21Z","timestamp":1523947281000},"page":"177-183","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparison of day 3 and day 5 thyroglobulin results after thyrogen injection in differentiated thyroid cancer patients"],"prefix":"10.1177","volume":"9","author":[{"given":"Sait","family":"Sager","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Istanbul University, Cerrahpa\u015fa Medical Faculty, Cerrahpa\u015fa, Fatih, Istanbul, 34452, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"Hatipoglu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burcak","family":"Gunes","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sertac","family":"Asa","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lebriz","family":"Uslu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerim","family":"S\u00f6nmezo\u011flu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2018,4,17]]},"reference":[{"key":"bibr1-2042018818770108","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29289"},{"key":"bibr2-2042018818770108","doi-asserted-by":"publisher","DOI":"10.1016\/j.yasu.2008.03.001"},{"key":"bibr3-2042018818770108","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ12-0128"},{"key":"bibr4-2042018818770108","doi-asserted-by":"publisher","DOI":"10.4158\/EP12244.RA"},{"key":"bibr5-2042018818770108","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-003-1190-5"},{"key":"bibr6-2042018818770108","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1109589"},{"key":"bibr7-2042018818770108","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.107.049072"},{"key":"bibr8-2042018818770108","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/HP.0b013e3182a82b37","volume":"106","author":"Dauer LT.","year":"2014","journal-title":"Health Phys"},{"key":"bibr9-2042018818770108","doi-asserted-by":"publisher","DOI":"10.1007\/s13139-016-0406-0"},{"key":"bibr10-2042018818770108","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0020"},{"key":"bibr11-2042018818770108","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2014.29.6.811"},{"key":"bibr12-2042018818770108","first-page":"881","volume":"32","author":"Coliez R","year":"1951","journal-title":"J Radiol Electrol Arch Electr Medicale"},{"key":"bibr13-2042018818770108","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1651"},{"key":"bibr14-2042018818770108","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0148"},{"key":"bibr15-2042018818770108","first-page":"3877","volume":"84","author":"Haugen BR","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"bibr16-2042018818770108","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2009.0187"},{"key":"bibr17-2042018818770108","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.050591"},{"key":"bibr18-2042018818770108","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2014.0586"},{"key":"bibr19-2042018818770108","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2528"},{"key":"bibr20-2042018818770108","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111301"}],"container-title":["Therapeutic Advances in Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2042018818770108","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2042018818770108","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2042018818770108","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:34:28Z","timestamp":1777592068000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/2042018818770108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,17]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["10.1177\/2042018818770108"],"URL":"https:\/\/doi.org\/10.1177\/2042018818770108","relation":{},"ISSN":["2042-0188","2042-0196"],"issn-type":[{"value":"2042-0188","type":"print"},{"value":"2042-0196","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,17]]}}}